Acetic Acid NDC 68071-1739

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-1739Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-1739Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-1739-5	68071173905	15 mL in 1 BOTTLE (68071-1739-5)Marketed from Aug 27, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acetic Acid
Generic name (nonproprietary): acetic acid
Active ingredients: Acetic acid — 20.65 mg/mL
Dosage form: Solution
Route: Auricular (Otic)
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 012179
Marketing start: Jan 22, 2010
Listing expires: Dec 31, 2026
Identifiers: Product ID 68071-1739_1d508056-bc55-575d-e063-6294a90a707bSPL ID 1d508056-bc55-575d-e063-6294a90a707bSPL set ID 7470a1ed-bc00-cb52-e053-2a91aa0a5c7dRxCUI 197305UNII Q40Q9N063PUPC 0368071173956

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N468071173905 followed by a unit qualifier and the quantity

Package 68071-1739-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)